Durham, CT, United States of America

John M Peterson



Average Co-Inventor Count = 4.9

ph-index = 8

Forward Citations = 190(Granted Patents)


Location History:

  • New Haven, CT (US) (1997 - 2002)
  • Madison, CT (US) (2002 - 2006)
  • Durham, CT (US) (2004 - 2010)

Company Filing History:


Years Active: 1997-2010

Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: **Innovative Contributions of John M Peterson in Pharmaceutical Patents**

Introduction

John M Peterson, an accomplished inventor based in Durham, CT, has made significant contributions to the field of pharmaceuticals, evidenced by his impressive portfolio of 26 patents. His innovations primarily focus on compounds that modulate ligand binding to histamine H3 receptors, which are crucial in the treatment of various disorders in both humans and animals.

Latest Patents

Among his latest patents, Peterson has developed several noteworthy compounds:

1. **Dipiperazinyl Ketones and Related Analogues** - These compounds offer methods for preparation and use, with applications in modulating ligand binding to histamine H3 receptors. They have potential therapeutic uses in treating various disorders in humans, domesticated companion animals, and livestock. Additionally, the patent provides pharmaceutical compositions and methods for detecting histamine H3 receptors.

2. **Thiazole Amides, Imidazole Amides and Related Analogues** - This patent presents compounds that modulate ligand binding to histamine H3 receptors, targeting both central nervous system (CNS) and other disorders. These compounds can be administered alone or in combination with other CNS agents to enhance their effects, along with pharmaceutical compositions and detection methods for histamine H3 receptors.

Career Highlights

Throughout his career, John M Peterson has worked with notable companies in the pharmaceutical industry, including Neurogen Corporation and Pfizer Corporation. His tenure at these organizations has greatly influenced his work, allowing him to innovate within the field.

Collaborations

Collaboration has been key to Peterson's success. He has partnered with esteemed colleagues such as Alan J Hutchison and Andrew Y Thurkauf, exchanging ideas that have propelled his inventive works further into the realm of pharmaceutical advancements.

Conclusion

John M Peterson's extensive patent portfolio and collaborative efforts reflect his commitment to advancing medical treatments through innovative pharmaceutical compounds. His work continues to have a significant impact on the modulation of histamine H3 receptors, paving the way for new therapeutic approaches in managing various health disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…